NEULOGIQ
LIVE

Serial Number

79411918

Owner

Cumulus Neuroscience Limited

Attorney

Steven J. Solomon

Filing Date

May 31, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NEULOGIQ Trademark

Serial Number: 79411918 • Registration: 7781412

NEULOGIQ is a trademark filed by Cumulus Neuroscience Limited on May 31, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cumulus Neuroscience Limited (5 trademarks)

The Innovation Centre, Unit 4,

Entity Type: 99

Trademark Details

Filing Date

May 31, 2024

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Medical services; medical screening and testing services; medical evaluation services for neurological diseases; medical examination being health assessment services; neurological and cognitive testing and analysis for medical purposes; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical advisory services, namely, measurement and prediction of response to medical treatments; human healthcare services, namely, neurology and psychiatric healthcare services; medical treatment services of neurological diseases, brain injuries and mental illnesses; medical diagnostic reporting services, namely, preparation of reports relating to medical matters; information, advisory and consultancy services in relation to the aforesaid services.

Design and development of computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; product development, namely, design and development of electronic apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; design and development of computer games software; design and development of computer software and mobile and tablet application software for the provision of medical and pharmaceutical information and reports; design and development of computer software and mobile and tablet application software for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological disease, brain injury or insult and mental illness in human beings and other animals; product development, namely, design and development of wireless headsets; product development, namely, design and development of wireless headsets for playing video games, computer games and games downloadable on mobile electronic devices; product development, namely, design and development of sensors and detectors for scientific use to be worn by a human to gather biometric data; design and development of computer software and mobile and tablet application software for the diagnosis and treatment of medical conditions including neurological disease, brain injury, and mental illness; design and development of computer software and mobile and tablet application software for therapeutic and medical treatment of disease including neurological disease, brain injury, and mental illness; information, advisory and consultancy services in relation to the aforesaid services.

Medical apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; medical apparatus and instruments, namely, sensors to be worn by a human for storing, relaying, tracking, measuring and displaying human cognitive and biometric data; medical apparatus and instruments for storing, relaying, tracking, and measuring the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury or insult and mental illness in human beings and other animals, and for displaying associated neurological and psychiatric data; medical diagnostic and testing apparatus and instruments for detecting neurological diseases, brain injuries and mental illnesses; medical apparatus and instruments, namely, electroencephalogram (EEG) for the therapeutic and medical treatment of disease including neurological disease, brain injury, and mental illness; parts and fittings for the aforesaid goods.

Downloadable computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; electronic scientific laboratory research apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; downloadable computer games software; downloadable computer software and applications for the provision of medical and pharmaceutical information and reports; downloadable computer software and applications for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury, insult and mental illness in human beings and other animals; wireless headsets for smartphones and tablet computers; wireless headsets for playing video games, computer games and games downloadable on mobile electronic devices; sensors and detectors for scientific use to be worn by a human to gather human biometric data; downloadable computer software and applications for neuroimaging for use in the diagnosis and treatment of medical conditions including neurological disease, brain injury, and mental illness; parts and fittings for the aforesaid goods.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 28, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 11, 2026 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 25, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 5, 2025 FICS
FINAL DISPOSITION PROCESSED
Dec 5, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 7, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2025 TROA
REFUSAL PROCESSED BY IB
Jan 17, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 31, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 31, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 15, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 14, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 13, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2024 REPR